Chemo4METPANC Combination Chemokine Inhibitor, Immunotherapy, and Chemotherapy in Pancreatic Adenocarcinoma

Clinical trial NCT04543071 · RECRUITING

Trial details

NCT number: NCT04543071
Sponsor: Gulam Manji
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Pancreatic Cancer Adenocarcinoma of the Pancreas Adenocarcinoma

Start date: 2020-11-09
Primary completion: 2028-06-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.